The association of venous thromboembolism with survival in pediatric cancer patients: a population-based cohort study
- 190 Downloads
Venous thromboembolism (VTE) is a well-recognized complication in pediatric oncology patients. Studies in adult oncology patients have suggested a potential negative association between VTE and survival, but this association has not been examined in pediatric patients yet. The aim of this study was to assess the association of VTE with survival in pediatric oncology patients. Data from all pediatric oncology patients treated at the two tertiary care centers in Atlantic Canada were pooled to create a population-based cohort. The association between VTE and survival was analyzed using a Cox proportional hazards model stratified by diagnosis group (leukemia, lymphoma, and other; sarcoma) and adjusted for age at diagnosis and sex. Out of 939 patients included in this study, 73 had a VTE (8%) and 131 (14%) patients died during the study period. Children in the leukemia/lymphoma/other group with a VTE had significantly poorer survival relative to children in the same group who did not have a VTE. Although children with sarcoma and VTE had poorer survival compared to children with sarcoma with no VTE, this association was not statistically significant. In this population-based study, we found a negative association between VTE and survival in pediatric oncology patients. If future studies confirm this association, this finding may have prognostic implications and potentially offer new avenues for the management of pediatric patients with cancer.
KeywordsPediatric oncology Population-based Survival Venous thromboembolism
The authors would like to acknowledge Stephanie Eason and Katherine Bowes for her work collecting the data on the patients treated at the Janeway Children’s Health and Rehabilitation Centre.
This work was supported by the MacKinnon fund at the IWK Health Centre and the Janeway Children’s Health and Rehabilitation Centre’s Hematology/Oncology department.
Compliance with ethical standards
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975 and its later amendments or comparable ethical standards.
Conflict of interest
The authors declare that they have no conflict of interest.
The need for consent for this retrospective study was waived due to impracticability as per the Nova Scotia Personal Health Information Act.
- 5.Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, Bernstein M, Brisson L, Cairney B, DeSai D (1994) Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 83(5):1251–1257Google Scholar
- 6.Monagle P, Adams M, Mahoney M, Ali K, Barnard D, Bernstein M, Brisson L, David M, Desai S, Scully MF, Halton J, Israels S, Jardine L, Leaker M, McCusker P, Silva M, Wu J, Anderson R, Andrew M, Massicotte MP (2000) Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 47(6):763–766CrossRefGoogle Scholar
- 9.Caruso V, Iacoviello L, Di Castelnuovo A, Storti S, Mariani G, de Gaetano G, Donati MB (2006) Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood 108(7):2216–2222. https://doi.org/10.1182/blood-2006-04-015511 CrossRefGoogle Scholar
- 10.Farinasso L, Bertorello N, Garbarini L, Gajno TM, Barisone E, Artesani L, Valori A, Giacchino M, Pastore G, Saracco P (2007) Risk factors of central venous lines-related thrombosis in children with acute lymphoblastic leukemia during induction therapy: a prospective study. Leukemia 21(3):552–556. https://doi.org/10.1038/sj.leu.2404560 CrossRefGoogle Scholar
- 11.Grace RF, Dahlberg SE, Neuberg D, Sallan SE, Connors JM, Neufeld EJ, Deangelo DJ, Silverman LB (2011) The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols. Br J Haematol 152(4):452–459. https://doi.org/10.1111/j.1365-2141.2010.08524.x CrossRefPubMedPubMedCentralGoogle Scholar
- 14.Lipay NV, Zmitrovich AI, Aleinikova OV (2011) Epidemiology of venous thromboembolism in children with malignant diseases: a single-center study of the Belarusian Center for Pediatric Oncology and Hematology. Thromb Res 128(2):130–134. https://doi.org/10.1016/j.thromres.2011.03.014 CrossRefGoogle Scholar
- 27.R core team (2016) R: a language and environment for statistical computing. R Foundation for Statistical ComputingGoogle Scholar
- 31.Tullius BP, Athale U, van Ommen CH, Chan AKC, Palumbo JS, Balagtas JMS, Hemostasis SoHaMatSoPNTa (2018) The identification of at-risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTH. J Thromb Haemost 16(1):175–180. https://doi.org/10.1111/jth.13895 CrossRefGoogle Scholar
- 33.Zacharski LR, Henderson WG, Rickles FR, Forman WB, Cornell CJ, Forcier RJ, Edwards R, Headley E, Kim SH, O’Donnell JR, O’Dell R, Tornyos K, Kwaan HC (1981) Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75. JAMA 245(8):831–835CrossRefGoogle Scholar